Cancer Immunology Immunotherapy Journal Citation Rate 2026
0340-7004
eISSN 1432-0851
Springer Science+Business Media
DE
Q1 Quartile Open Access Established Impact
About Cancer Immunology Immunotherapy
Cancer Immunology Immunotherapy (CII) is a peer-reviewed academic journal covering CAR-T cell therapy research and Cancer Immunotherapy and Biomarkers, published by Springer Science+Business Media in DE, catalogued under ISSN 0340-7004 (e-ISSN 1432-0851). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 4.62 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $4390 USD.
Cancer Immunology Immunotherapy Citation Rate 2026 — In Context
Cancer Immunology Immunotherapy has a 2025 2-Year Citation Rate (OpenAlex) of 4.62, placing it in the Q1 quartile within the CAR-T cell therapy research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, Cancer Immunology Immunotherapy makes all articles freely available to readers for an Article Processing Charge of approximately $4390 USD.
Researchers looking to publish in Cancer Immunology Immunotherapy should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Cancer Immunology Immunotherapy against similar journals in the field, use our journal comparison tool.
Submission Tips for Cancer Immunology Immunotherapy
- Budget $4390 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cancer Immunology Immunotherapy Compares
Compared against 31 journals in the same research areas.
| ISSN (Print) | 0340-7004 |
|---|---|
| ISSN (Online) | 1432-0851 |
| Publisher | Springer Science+Business Media |
| Country | Germany |
| APC / Cost | $4390 USD |
In-depth profile & metrics
Cancer Immunology Immunotherapy is published by Springer Science+Business Media and based in Germany. It publishes open access with an article-processing charge of USD 4390.
In our subject taxonomy, Cancer Immunology Immunotherapy is classified under CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction and Immunotherapy and Immune Responses.
Cancer Immunology Immunotherapy is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 4.624.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Cancer Immunology Immunotherapy
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 4.624 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Cancer Immunology Immunothera… against similar publications in its field:
Related Journals in Your Field
-
Immunity Cell Press IF 19.59
-
Immunological Reviews Wiley IF 8.21
-
Journal for ImmunoTherapy of Cancer BMJ IF 7.57
-
JCI Insight American Society for Clinical Investigation IF 5.03
-
Retrovirology BioMed Central IF 4.76
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S203303425
Get weekly updates for CAR-T cell therapy research journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.